Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
Edwards Lifesciences history
Edwards Lifesciences company history timeline
A pivotal moment in Edwards’s career occurred in the late spring of 1958, when the 60 year old Edwards introduced himself to a 32-year-old cardiac surgeon, Albert Starr.
In 1963, Starr and Edwards reported their clinical experience with aortic valve replacement with what they termed their “semi-rigid ball-valve prosthesis.” Aortic Replacement: Clinical Experience with a Semirigid Ball-Valve Prosthesis.
In 1966, Edwards Laboratories was purchased by American Hospital Supply Corporation and became American Edwards Laboratories.
Edwards was acquired by Baxter in 1985.
In early 2000, the company was spun-off as an independent, publicly-held corporation and began trading on the New York Stock Exchange under the symbol “EW.”
Harpoon, founded in 2013, developed a minimally invasive heart surgery product for mitral valve repair to treat degenerative mitral regurgitation.
On January 25, 2017, Edwards completed the acquisition of Valtech Cardio for $340 million.
On April 18, 2019, Edwards completed the acquisition of CAS Medical Systems of Branford, Connecticut for ~$100 million.
Edwards SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve systems were FDA-approved for the treatment of patients at low risk for death or major complications associated with open-heart surgery on August 16, 2019.
Rate Edwards Lifesciences' efforts to communicate its history to employees.
Edwards Lifesciences jobs
Do you work at Edwards Lifesciences?
Is Edwards Lifesciences' vision a big part of strategic planning?
Edwards Lifesciences competitors
| Company Name | Founded Date | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| Boston Scientific | 1979 | $12.7B | 36,000 | 549 |
| Stryker | 1941 | $18.4B | 43,000 | 2,191 |
| Seagen | 1997 | $2.0B | 900 | 19 |
| Baxter International | 1931 | $15.1B | 48,000 | 319 |
| Amgen | 1980 | $26.3B | 22,000 | 803 |
| Danaher | 1969 | $31.5B | 80,000 | 2,424 |
| Gilead Sciences | 1987 | $27.3B | 11,800 | 634 |
| Beckman Coulter | 1935 | $3.7B | 12,000 | 177 |
| Johnson & Johnson | 1886 | $94.9B | 134,500 | 2,200 |
| Hospira | 2004 | $4.5B | 19,000 | 32 |
Edwards Lifesciences history FAQs
Zippia gives an in-depth look into the details of Edwards Lifesciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Edwards Lifesciences. The employee data is based on information from people who have self-reported their past or current employments at Edwards Lifesciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Edwards Lifesciences. The data presented on this page does not represent the view of Edwards Lifesciences and its employees or that of Zippia.
Edwards Lifesciences may also be known as or be related to Edwards Lifesciences, Edwards Lifesciences (Japan) Ltd., Edwards Lifesciences Corp, Edwards Lifesciences Corporation and Edwards Lifesciences LLC.